Latest Conference Articles

The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.

The Ketamine & Esketamine Care Teams, and Necessary Monitoring

The Ketamine & Esketamine Care Teams, and Necessary Monitoring

May 24th 2022, 1:28pm

With administration strategies for the psychiatric anesthetic drug well established, clinicians have interest in accumulating long-term data and other potential indications.

Blood Biomarkers, Aducanumab and Setting Precedent for Dementia Care Advances

Blood Biomarkers, Aducanumab and Setting Precedent for Dementia Care Advances

May 24th 2022, 12:19pm

Brent Forester, MD, MSc, discusses the confluence of biomarker and disease-targeting therapy in Alzheimer's, and the need to appropriately introduce these tools.

Nora D. Volkow, MD: Combating COVID-Era Issues in Substance Use Disorder

Nora D. Volkow, MD: Combating COVID-Era Issues in Substance Use Disorder

May 24th 2022, 12:21am

The director of NIDA discusses the unprecedented impact of the pandemic on overdose deaths—and how substance use disorder care may still reach greater capability when all is said and done.

The Challenges to Identifying Dementia, Alzheimer-Risk Patients

The Challenges to Identifying Dementia, Alzheimer-Risk Patients

May 23rd 2022, 11:43pm

Dementia and Alzheimer's disease cases are anticipated to boom in coming decades. One expert stressed the need for improved screening and facilitation of care at the earliest stages and signs.

CP101 Prevented Recurrence of C Difficile Infection in PRISM-EXT Trial

CP101 Prevented Recurrence of C Difficile Infection in PRISM-EXT Trial

May 23rd 2022, 11:30pm

Digestive Disease Week

Data show the proportion of individuals with sustained clinical cure through Week 8 was 80.3% with CP101 treatment.

Guiding Appropriate Ketamine, Esketamine Use in Psychiatry

Guiding Appropriate Ketamine, Esketamine Use in Psychiatry

May 23rd 2022, 11:10pm

The lead author of treatment recommendations weighs in on their current use and future research.

Raseen Tariq, MBBS: FMT for Refractory Host Versus Graft Disease

Raseen Tariq, MBBS: FMT for Refractory Host Versus Graft Disease

May 23rd 2022, 10:50pm

Digestive Disease Week

Initial studies have shown a 73% efficacy for FMT in treating patients with HVGD.

Lack of Association Observed Between BMI and Mortality Among C Difficile Hospitalizations

Lack of Association Observed Between BMI and Mortality Among C Difficile Hospitalizations

May 23rd 2022, 10:45pm

Digestive Disease Week

BMI did not have an association with increased risk for death in any BMI category, according to study investigators.

Miguel Regueiro, MD: Safety Data on Ozanimod for Ulcerative Colitis

Miguel Regueiro, MD: Safety Data on Ozanimod for Ulcerative Colitis

May 23rd 2022, 9:00pm

Digestive Disease Week

A look into the efficacy of ozanimod in patients with UC and the potential risk for cardiovascular events.

SER-109 Results in Increase in Microbe-Producing Metabolites

SER-109 Results in Increase in Microbe-Producing Metabolites

May 23rd 2022, 7:49pm

Digestive Disease Week

The live microbiota therapeutic has shown promise in treating patients with recurrent CDI.